GSK3B and neoplasm: have reported that energy sensor AMPK was markedly reduced in tumour‐infiltrating Tregs, which can enhance the PD‐1 expression of Tregs via the HMGCR/p38 MAPK/GSK3β signalling axis and further suppress tumour progression in an LKB1‐independent manner.134